Cargando…
No association between a candidate TCF7L2 variant and risk of breast or ovarian cancer
BACKGROUND: TCF7L2 is a transcription factor involved in Wnt/β-catenin signaling which has a variant known to be associated with risk of Type 2 diabetes and, in some studies, with risk of certain cancers, including familial breast cancer. No studies of ovarian cancer have been reported to date. METH...
Autores principales: | Goode, Ellen L, Szabo, Csilla, Prokunina-Olsson, Ludmila, Vierkant, Robert A, Fredericksen, Zachary S, Collins, Francis S, White, Kristin L, Schmidt, Michele, Fridley, Brooke L, Couch, Fergus J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749057/ https://www.ncbi.nlm.nih.gov/pubmed/19732438 http://dx.doi.org/10.1186/1471-2407-9-312 |
Ejemplares similares
-
Alternative Splicing of TCF7L2 Gene in Omental and Subcutaneous Adipose Tissue and Risk of Type 2 Diabetes
por: Prokunina-Olsson, Ludmila, et al.
Publicado: (2009) -
Risk of Ovarian Cancer and Inherited Variants in Relapse-Associated Genes
por: Peedicayil, Abraham, et al.
Publicado: (2010) -
No effect of cancer-associated SNP rs6983267 in the 8q24 region on co-expression of MYC and TCF7L2 in normal colon tissue
por: Prokunina-Olsson, Ludmila, et al.
Publicado: (2009) -
Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival
por: Jatoi, Aminah, et al.
Publicado: (2015) -
Evidence for neuroendocrine function of a unique splicing form of TCF7L2 in human brain, islets and gut
por: Prokunina-Olsson, L., et al.
Publicado: (2009)